Good Writing Practice - Volume 32, Issue

Author: Michael Lewis Schneir Section Editors: Wendy Kingdom, Amy Whereat Syntactic punctuation distraction Comma: Over-usage Part 2 Coordinated noncore sentence constituents are likely to be disrupted by unnecessary comma punctuation. Medical…

Good Writing Practice - Volume 33, Issue

Section Editors: Wendy Kingdom, Amy Whereat Syntactic alternatives and distractions: Title to a journal article Author: Michael Lewis Schneir, PhD Medical Writing. 2024;33(1):110. https://doi.org/10.56012/xjow9091

Good Writing Practice - Volume 34, Issue

Section Editors: Wendy Kingdom, Amy Whereat   Distractions in the introduction section of a journal article Author: Michael Lewis Schneir Medical Writing. 2025;34(1):77. https://doi.org/10.56012/scgm1052

Editorial - Volume 31, Issue

Medical devices are at the core of healthcare forming a large share of the global healthcare market. With consistent advances in technology, MedTech is enhancing our lives more so now than a few decades ago owing to accelerated digitisation and…

Post-approval regulatory writing - Volume 23, Issue

Freelancing - Volume 33, Issue

Section Editor: Adriana Rocha Navigating my freelance journey while driving EMWA freelance activities Author: Laura A. Kehoe I didn’t plan to become a medical writer, but then again who does? It wasn’t, at the time, a career on the list of things…

Subcontracting: Not for the faint of heart - Volume 28, Issue

Subcontracting can be the answer to a successful freelancer’s prayers, or the opportunity to work harder than you have ever worked before for less money than you made when you were a struggling newbie. The potential advantages of subcontracting are…

Regulatory Matters - Volume 32, Issue

Current clinical trial disclosure landscape in China Author and Section Editor: Zuo Yen Lee Section Editor: Clare Chang In China, before the launch of the current national clinical trial registry in 2013, i.e., ChinaDrugTrials.org.cn…

Risk Management - Volume 24, Issue

The thalidomide tragedy of the early 1960s cost several thousand lives, but it ultimately led to changes that will undoubtedly save many thousands more: it triggered a chain of events involving the WHO and the ICH that resulted in the…

Making the leap: Transparency requirements for clinical trials moving from one regulatory framework to another - Volume 33, Issue

This article discusses the fast-approaching deadline for sponsors to transition ongoing clinical trials in the EU/European Economic Area from the Clinical Trials Directive 2001/20/EC to the Clinical Trials Regulation 536/2014. In particular, the…